Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efzofitimod in severe COVID-19 pneumonia
NCT04412668Phase 2Completed
- Sponsor
- aTyr Pharma
- Start
- Jun 2020
- Primary completion
- Oct 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of efzofitimod in COVID-19 pneumonia, sponsored by aTyr Pharma. Started Jun 2020; status: completed.
02
Drugs
efzofitimod
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04412668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412668.